Preliminary results from Bates and colleagues highlighted that delivering 8 Gy in a single fraction associated with fulvestrant could trigger a valid TME switch and a satisfying response to IT (antiPD-L1) in a cold estrogen receptor positive breast cancer model [29]. The gene discussed is ESR1; the disease is breast carcinoma.